Mepyramine, one of the HRH1-specific antihistamines highly associated with atherosclerosis, has already been shown to decrease the formation of atherogenic plaques in a mouse model of the disease (Rozenberg et al., 2010). Here, HRH1 is linked to atherosclerosis.